Fight CRC Clinical Trial Finder
| NCT ID | Title | Phase | Date Added | Location | Prior IO Allowed | CRC-directed | Status | Drugs | Tags |
|---|---|---|---|---|---|---|---|---|---|
| NCT ID NCT04111172 |
TitleA Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma | Phase
Phase 2
|
Date Added 2019-10-01 |
Location
Pennsylvania, United States
|
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Active, not recruiting
|
Drugs
Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03547999 |
TitleA Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC | Phase
Phase 2
|
Date Added 2018-06-06 |
Location
California, United States
Florida, United States Kansas, United States New Jersey, United States Ohio, United States Oregon, United States |
Prior IO Allowed Yes |
CRC-directed Yes |
Status
Active, not recruiting
|
Drugs
FPV-CV301, mFOLFOX6, MVA-BN-CV301, Nivolumab |
Tags
MSS/ MMRp
|
| NCT ID NCT03673787 |
TitleA Trial of Ipatasertib in Combination With Atezolizumab | Phase
Phase 1
|
Date Added 2018-09-17 |
Location
United Kingdom
|
Prior IO Allowed Yes |
CRC-directed No |
Status
Recruiting
|
Drugs
Atezolizumab, Ipatasertib |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03990233 |
TitleA Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours | Phase
Phase 1
|
Date Added 2019-06-18 |
Location
Belgium
France |
Prior IO Allowed Yes |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
BI 754091, BI 765063 |
Tags
MSS/ MMRp
|
| NCT ID NCT04973163 |
TitleA Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation | Phase
Phase 1
|
Date Added 2021-07-22 |
Location
Texas, United States
Belgium Spain United Kingdom |
Prior IO Allowed No |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
BI 1701963, BI 1823911, Midazolam |
Tags
MSS/ MMRp
|
| NCT ID NCT04111458 |
TitleA Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) | Phase
Phase 1
|
Date Added 2019-10-01 |
Location
Massachusetts, United States
North Carolina, United States Tennessee, United States Texas, United States Germany Netherlands |
Prior IO Allowed Yes |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
BI 1701963, Trametinib |
Tags
MSS/ MMRp
|
| NCT ID NCT05487235 |
TitleA Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors | Phase
Phase 1
|
Date Added 2022-08-04 |
Location
Argentina
Australia Brazil Canada Korea, Republic of New Zealand |
Prior IO Allowed Yes |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
Atezolizumab, GDC-1971, Omeprazole |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT03530397 |
TitleA Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors | Phase
Phase 1
|
Date Added 2018-05-21 |
Location
Michigan, United States
New York, United States North Carolina, United States Rhode Island, United States Tennessee, United States Virginia, United States Australia France Italy Korea, Republic of Netherlands Portugal Spain Taiwan |
Prior IO Allowed Yes |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
Carboplatin, MEDI5752, Pembrolizumab, Pemetrexed, Alimta, Imfinzi, Keytruda, Paraplatin |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
| NCT ID NCT05879822 |
TitleA Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive | Phase
Phase 2
|
Date Added 2023-05-30 |
Location
Brazil
China Georgia Greece Hungary New Zealand Romania South Africa Turkey |
Prior IO Allowed No |
CRC-directed No |
Status
Active, not recruiting
|
Drugs
INCB099280 |
Tags
MSI-H/ MMRd
|
| NCT ID NCT06322693 |
TitleA Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) | Phase
Phase 1
|
Date Added 2024-03-21 |
Location
Arizona, United States
California, United States Colorado, United States Connecticut, United States District of Columbia, United States Florida, United States Georgia, United States Illinois, United States Iowa, United States Kansas, United States Kentucky, United States Maryland, United States Massachusetts, United States Michigan, United States Minnesota, United States New Jersey, United States New York, United States Ohio, United States Oregon, United States Pennsylvania, United States South Carolina, United States Tennessee, United States Texas, United States Virginia, United States Washington, United States Wisconsin, United States Korea, Republic of Spain |
Prior IO Allowed No |
CRC-directed Yes |
Status
Recruiting
|
Drugs
Carboplatin, cisplatin, Docetaxel, Nivolumab, Pemetrexed, TSR-022, TSR-033, TSR-042 |
Tags
MSI-H/ MMRd, MSS/ MMRp
|
